About Us
Pioneers in precision genomics
Foresight Diagnostics was founded by four Stanford University physicians and scientists who sought to develop high-performing circulating tumor DNA (ctDNA) assays by improving the limits of detection through innovative techniques and enhanced bioinformatics. Our first product, Foresight CLARITY™, utilizes a proprietary and patented phased variant (PV) detection method to improve the accuracy of ctDNA tests and minimal residual disease (MRD) measurement.
Since our founding in 2020…
Authored 40+ scientific publications and presentations

Raised $86M from institutional VC’s

Partnered with 30+ biopharma and academic researchers

Established an automated and scalable CLIA-certified lab in Boulder, Colorado
Our Investors






